Since the dismantling of the U.S. Agency for International Development, or USAID, the Trump administration has been revamping aid policies, focusing on smaller, narrowly focused deals with recipient governments.

They will be required to finance part, and it's hoped eventually entire programs now receiving American assistance.

In his second report, Fred de Sam Lazaro reports from Kenya and Uganda,

two nations that have signed agreements under the new America First Global Health Strategy.

On a recent afternoon in this Nairobi Public Health Center,

Evelyn Minayo was girding herself

for a dose of perhaps the most significant drug developed so far against HIV.

Minio is considered at high risk for the virus, but on Lena Capovir, she'll be protected.

Linna Capovir is not the first HIV prevention drug.

There have been daily oral medications, for example, but this one is called a game changer

because it's just one dose taken every six months, and it's been found nearly 100% effective

in preventing HIV infection.

Lena Capovir is also the first drug made accessible in low-income countries

soon after its release in rich nations.

Why Searly Prep is here?

It was approved just last June by the Food and Drug Administration in the U.S.

where it is sold under the brand name Yes Tugo.

The list price in America is $14,000 per dose, but under an agreement with the U.S. government,

its maker, California-based Gillian Sciences, is making Lena Capavir available for 2 million people

at, quote, no profit, targeting patients in several nations that the U.S. has approached

with a new model for health care assistance.

Sometimes I forget to take the pills, so this gives me some reassurance that I won't get infected.

...